Recombinant Human Fas/CD95/TNFRSF6 Protein (His Tag)
Recombinant Human Fas/CD95/TNFRSF6 Protein (His Tag) supplied by Elabscience with collaborator-provided technical specifications. Read more ›
["Measured by its ability to inhibit Fas Ligand induced apoptosis of Jurkat human acute T cell leukemia cells. The ED50 for this effect is typically 3-15 μg/mL in the presence of 20 ng/mL recombinant human Fas ligand. ,"]Product Description
Fas/CD95/TNFRSF6 is the stated recombinant protein target for this Elabscience product. The listing uses collaborator-supplied specifications to support research-use-only protein selection through ABMIUM.
Protein profile: reactive species/source: Human; expression system: HEK293 Cells; physical form: Lyophilized from sterile PBS, pH 7.4<br/>Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.<br/>Please refer to the specific buffer information in the printed manual.; tag: Human ,Fas/CD95/TNFRSF6 ,Recombinant Proteins; predicted molecular weight: 18.2 kDa.
Quality and formulation: purity: > 95 % as determined by reducing SDS-PAGE.; endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method..
Functional evidence: activity: Measured by its ability to inhibit Fas Ligand induced apoptosis of Jurkat human acute T cell leukemia cells. The ED<sub>50</sub> for this effect is typically 3-15 μg/mL in the presence of 20 ng/mL recombinant human Fas ligand.. In the ABMIUM matrix, collaborator-supplied functional evidence is marked C; unsupported application columns remain N.
Sequence coverage: 18.2 kDa.
Database references: UniProt: NP_000034.1 | NCBI Gene: 355 | Gene symbol: Fas/CD95/TNFRSF6.
Research Use Only.
Key Facts
| Target | Fas/CD95/TNFRSF6 |
| Also known as | ALPS1A, APO-1, APT1, Apo-1 antigen, Apoptosis-mediating surface antigen FAS, CD95, FAS1, FASLG receptor, FASTM, TNFRSF6 and FAS, Tumor necrosis factor receptor superfamily member 6 |
| Species reactivity | Human |
| Purity | > 95 % as determined by reducing SDS-PAGE. |
| Form / buffer | Lyophilized from sterile PBS, pH 7.4 Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
| Shelf life | 12 months |
| Research area | Cell biology, immunology |
| BIOACTIVITY | BINDING | CELL-BASED | IN VIVO | ELISA CAPTURE | |
|---|---|---|---|---|---|
| Human |
Specifications
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.